Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 201

Related Citations for PubMed (Select 11531850)

1.

Hydroa vacciniforme with latent Epstein-Barr virus infection.

Ohtsuka T, Okita H, Otsuka S, Yamakage A, Yamazaki S.

Br J Dermatol. 2001 Sep;145(3):509-10. No abstract available.

PMID:
11531850
2.

Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children.

Xu Z, Lian S.

Pediatr Dermatol. 2010 Sep-Oct;27(5):463-9. doi: 10.1111/j.1525-1470.2010.01094.x.

PMID:
20497358
3.

The association of latent Epstein-Barr virus infection with hydroa vacciniforme.

Iwatsuki K, Xu Z, Takata M, Iguchi M, Ohtsuka M, Akiba H, Mitsuhashi Y, Takenoshita H, Sugiuchi R, Tagami H, Kaneko F.

Br J Dermatol. 1999 Apr;140(4):715-21.

PMID:
10233328
4.
5.

A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.

Yamamoto T, Tsuji K, Suzuki D, Morizane S, Iwatsuki K.

J Microbiol Methods. 2007 Feb;68(2):403-7. Epub 2006 Dec 1.

PMID:
17141343
6.

Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.

Wu YH, Chen HC, Hsiao PF, Tu MI, Lin YC, Wang TY.

Int J Dermatol. 2007 Oct;46(10):1081-6.

PMID:
17910721
7.

Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up.

Verneuil L, Gouarin S, Comoz F, Agbalika F, Creveuil C, Varna M, Vabret A, Janin A, Leroy D.

Br J Dermatol. 2010 Jul;163(1):174-82. doi: 10.1111/j.1365-2133.2010.09789.x. Epub 2010 Mar 29.

PMID:
20367637
8.

Atypical hydroa vacciniforme in childhood: from a smoldering stage to Epstein-Barr virus-associated lymphoid malignancy.

Iwatsuki K, Ohtsuka M, Akiba H, Kaneko F.

J Am Acad Dermatol. 1999 Feb;40(2 Pt 1):283-4. No abstract available.

PMID:
10025766
9.

Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions.

Cho KH, Kim CW, Heo DS, Lee DS, Choi WW, Rim JH, Han WS.

Clin Exp Dermatol. 2001 May;26(3):242-7.

PMID:
11422165
10.

Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.

Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S, Ohtsuka M, Xu ZG, Suzuki D, Tsuji K.

Arch Dermatol. 2006 May;142(5):587-95.

PMID:
16702496
11.

Hydroa vacciniforme present for 48 years with cytotoxic CD4+ T-cell infiltration and Epstein-Barr virus infection.

Xie JL, Chen GY, Jin Y, Zheng XD, Wei XJ, Zheng YY, Zhang SH, Zhang YN, Zhang XJ, Zhou XG.

Br J Dermatol. 2012 Feb;166(2):449-51. doi: 10.1111/j.1365-2133.2011.10556.x. Epub 2011 Nov 3. No abstract available.

PMID:
21801161
12.

Hydroa vacciniforme-like Epstein-Barr virus-associated lymphoproliferative disease: a case report.

Zeng Y, Fu L, Jin H, Sun Q, Wang B.

Pediatr Dermatol. 2012 Jan-Feb;29(1):96-100. doi: 10.1111/j.1525-1470.2011.01399.x. Epub 2011 Oct 13.

PMID:
21995788
13.

Antiviral therapy in children with hydroa vacciniforme.

Lysell J, Wiegleb Edström D, Linde A, Carlsson G, Malmros-Svennilson J, Westermark A, Andersson J, Wahlgren CF.

Acta Derm Venereol. 2009;89(4):393-7. doi: 10.2340/00015555-0670.

14.

Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases.

Cho KH, Lee SH, Kim CW, Jeon YK, Kwon IH, Cho YJ, Lee SK, Suh DH, Chung JH, Yoon TY, Lee SJ.

Br J Dermatol. 2004 Aug;151(2):372-80.

PMID:
15327544
15.

Oculomucosal and gastrointestinal involvement in Epstein-Barr virus-associated hydroa vacciniforme.

Yamamoto T, Hirai Y, Miyake T, Yamasaki O, Morizane S, Iwatsuki K.

Eur J Dermatol. 2012 May-Jun;22(3):380-3. doi: 10.1684/ejd.2012.1665.

PMID:
22361979
16.

[Hypersensitivity to mosquito bites and hydroa vacciniforme].

Iwatsuki K, Yamamoto T, Tsuji K.

Nihon Rinsho. 2006 Mar;64 Suppl 3:657-61. Review. Japanese. No abstract available.

PMID:
16615554
17.

Phenotypic analysis in a case of hydroa vacciniforme-like eruptions associated with chronic active Epstein-Barr virus disease of γδ T cells.

Tanaka C, Hasegawa M, Fujimoto M, Iwatsuki K, Yamamoto T, Yamada K, Kawa K, Saikawa Y, Toga A, Mase S, Wada T, Takehara K, Yachie A.

Br J Dermatol. 2012 Jan;166(1):216-8. doi: 10.1111/j.1365-2133.2011.10512.x. No abstract available.

PMID:
21729029
18.

Severe mosquito bite hypersensitivity, natural killer cell leukaemia, latent or chronic active Epstein-Barr virus infection and hydroa vacciniforme-like eruption.

Tokura Y, Ishihara S, Ohshima K, Hidano A, Koide M, Seo N, Takigawa M.

Br J Dermatol. 1998 May;138(5):905-6. No abstract available.

PMID:
9666846
19.

Epstein-Barr virus: dermatologic associations and implications: part I. Mucocutaneous manifestations of Epstein-Barr virus and nonmalignant disorders.

Hall LD, Eminger LA, Hesterman KS, Heymann WR.

J Am Acad Dermatol. 2015 Jan;72(1):1-19; quiz 19-20. doi: 10.1016/j.jaad.2014.07.034. Review.

PMID:
25497917
20.

Hydroa vacciniforme-like eruptions in a patient with chronic active EB virus infection.

Katagiri Y, Mitsuhashi Y, Kondo S, Kanazawa C, Iwatsuki K, Tsunoda T.

J Dermatol. 2003 May;30(5):400-4.

PMID:
12773806
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk